Renasant Bio
PrivateLast Round
Seed
Jul 10, 2025
Total Funding Raised
$54.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Renasant Bio is a biopharmaceutical company developing oral small molecule corrector and potentiator therapies to target the underlying biology of autosomal dominant polycystic kidney disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Renasant Bio Comparables
Compare Renasant Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mironid | 84% | |
| Vertex Pharmaceuticals | 74% | |
| Otsuka Holdings | 73% | |
Renasant Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 10, 2025 |
Renasant Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OrbiMed | Seed |
| 5AM Ventures | Seed |
| Qiming | Seed |
| Atlas Venture | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 2, 2026
Grew 18% QoQ, from 28 to 33 employees.
- May 16, 2026
Monthly visitors increased 540% MoM.
Renasant Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Renasant Bio's valuation, stock price, and market status.